Hyong Kim Sells 35,951 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Posted by Geri Gentry on Jun 15th, 2026

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) insider Hyong Kim sold 35,951 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the completion of the transaction, the insider owned 331,750 shares of the company’s stock, valued at approximately $6,588,555. This represents a 9.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hyong Kim also recently made the following trade(s):

On Wednesday, March 18th, Hyong Kim sold 18,404 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.84, for a total value of $328,327.36.

Alignment Healthcare Price Performance

Shares of ALHC stock traded up $0.03 during mid-day trading on Monday, reaching $19.78. The stock had a trading volume of 4,684,470 shares, compared to its average volume of 4,265,832. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87. The company has a market cap of $4.09 billion, a P/E ratio of 219.78, a price-to-earnings-growth ratio of 2.67 and a beta of 1.14. The business has a 50-day simple moving average of $18.53 and a 200 day simple moving average of $19.41. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter last year, the business posted ($0.05) earnings per share. The business’s revenue for the quarter was up 33.3% on a year-over-year basis. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ALHC. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. UBS Group lifted their price objective on Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Raymond James Financial set a $22.00 price objective on Alignment Healthcare in a research report on Thursday, May 7th. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Finally, Wolfe Research began coverage on Alignment Healthcare in a research report on Friday, April 17th. They set an “outperform” rating and a $24.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Read Our Latest Research Report on Alignment Healthcare

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALHC. Vanguard Group Inc. grew its holdings in Alignment Healthcare by 10.9% in the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after buying an additional 1,524,218 shares during the period. Wellington Management Group LLP grew its holdings in Alignment Healthcare by 26.9% in the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after buying an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in Alignment Healthcare by 0.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after buying an additional 79,268 shares during the period. Invesco Ltd. grew its holdings in Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after buying an additional 1,735,962 shares during the period. Finally, 8 Knots Management LLC grew its holdings in Alignment Healthcare by 6.4% in the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after buying an additional 300,409 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.